Showing results (201-210 of 301) with videos related to
Sort By:
Pageof 31
Cancer|June 1, 1983
Adriamycin and Cytoxan in the treatment of inoperable lung cancerT M Hoeltgen, J M MacIntyre, C P Perlia, et al.Cancer|December 1, 1989
Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative StudyD R Head, K Kopecky, J M Bennett, et al.Cancer Chemotherapy Reports|March 1, 1975
Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowelJ Horton, A Mittelman, S G Taylor, et al.Leukemia Research|December 5, 2021
The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-TJ Kaivers, J Peters, C Rautenberg, et al.Case Reports in Hematology|July 21, 2021
A Case of Acute Eosinophilic Leukemia with a Novel PHF6 MutationJ J Lipof, E J Huselton, C S Zent, et al.Leukemia|July 29, 2000
Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17)J M Bennett, D Catovsky, M T Daniel, et al.Cancer|February 19, 1999
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot studyM S Tallman, S Lee, B I Sikic, et al.Blood|April 1, 1984
A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemiaP A Cassileth, C B Begg, J M Bennett, et al.Cancer|May 1, 1978
Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphomaE Z Ezdinli, W Costello, R E Lenhard, et al.British Journal of Haematology|August 1, 1994
The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia GroupJ M Bennett, D Catovsky, M T Daniel, et al.Pageof 31